These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2894163)

  • 1. Noninvasive study of cardiac structure and function after rilmenidine for essential hypertension.
    N'guyen van Cao A; Levy B; Slama R
    Am J Cardiol; 1988 Feb; 61(7):72D-75D. PubMed ID: 2894163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and electrophysiologic effects of a new alpha 2-adrenoceptor agonist, rilmenidine, for systemic hypertension.
    Zannad F; Aliot E; Florentin J; Saulnier JP; Gilgenkrantz JM
    Am J Cardiol; 1988 Feb; 61(7):67D-71D. PubMed ID: 2894162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive efficacy and acceptability of rilmenidine in elderly hypertensive patients.
    Galley P; Manciet G; Hessel JL; Michel JP
    Am J Cardiol; 1988 Feb; 61(7):86D-90D. PubMed ID: 2894166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effort blood pressure control in the course of antihypertensive treatment.
    de Divitiis O; Di Somma S; Liguori V; Petitto M; Magnotta C; Ausiello M; Natale N; Brignoli M; Galderisi M
    Am J Med; 1989 Sep; 87(3C):46S-56S. PubMed ID: 2782327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and acceptability of rilmenidine for mild to moderate systemic hypertension.
    Ostermann G; Brisgand B; Schmitt J; Fillastre JP
    Am J Cardiol; 1988 Feb; 61(7):76D-80D. PubMed ID: 2894164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and tolerance of rilmenidine in patients with mild to moderate hypertension. Results of a Czech and Slovak 6-month multicenter study].
    Widimský J
    Vnitr Lek; 2002 Aug; 48(8):724-9. PubMed ID: 12425202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients.
    Fillastre JP; Letac B; Galinier F; Le Bihan G; Schwartz J
    Am J Cardiol; 1988 Feb; 61(7):81D-85D. PubMed ID: 2894165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients.
    Trimarco B; Rosiello G; Sarno D; Lorino G; Rubattu S; DeLuca N; Volpe M
    Am J Cardiol; 1994 Dec; 74(13):36A-42A. PubMed ID: 7998584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of rilmenidine for arterial hypertension.
    Beau B; Mahieux F; Paraire M; Laurin S; Brisgand B; Vitou P
    Am J Cardiol; 1988 Feb; 61(7):95D-102D. PubMed ID: 2894168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of rilmenidine on arterial parameters in essential arterial hypertension].
    Pannier B; Safar M
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():47-51. PubMed ID: 2517009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension: comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist.
    Koldas L; Ayan F; Ikitimur B
    Jpn Heart J; 2003 Sep; 44(5):693-704. PubMed ID: 14587651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
    Sadowski Z; Szwed H; Kuch-Wocial A; Kubasik A; Januszewicz W; Krupa-Wojciechowska B; Polak G; Stejfa M; Dvorak I; Balazovjech I; Dubai G; Simon K
    J Hypertens Suppl; 1998 Aug; 16(3):S55-62. PubMed ID: 9747912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
    Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
    Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive monotherapy and cardiovascular responses to an acoustic startle stimulus.
    Girard A; Holand S; Laude D; Elghozi JL
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):101-7. PubMed ID: 11152367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine.
    Callens-el Amrani F; Paolaggi F; Swynghedauw B
    J Hypertens; 1989 Dec; 7(12):947-54. PubMed ID: 2576430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rilmenidine on 24-h rhythmicity of blood pressure and spontaneous baroreflex sensitivity in essential hypertensive subjects.
    Finta E; Laude D; Alföldi S; Farsang C; Elghozi JL
    J Hypertens; 2006 Aug; 24(8):1619-25. PubMed ID: 16877965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of systemic hypertension in insulin-treated diabetes mellitus with rilmenidine.
    Mpoy M; Vandeleene B; Ketelslegers JM; Lambert AE
    Am J Cardiol; 1988 Feb; 61(7):91D-94D. PubMed ID: 2894167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol counteraction of I1-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):455-62. PubMed ID: 9918545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of two centrally-acting anti-hypertensive drugs on the quality of life.
    Fletcher AE; Beevers DG; Dollery CT; Wilkinson R; Bulpitt CJ
    Eur J Clin Pharmacol; 1991; 41(5):397-400. PubMed ID: 1684749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.